Protein & Cell >

2020 , Vol. 11 >Issue 7: 525 - 533

DOI: https://doi.org/10.1007/s13238-020-00696-9

LETTER

Human cytomegalovirus DNA and immediate early protein 1/2 are highly associated with glioma and prognosis

  • Le Wen 1,2 ,
  • Fei Zhao 3 ,
  • Yong Qiu 4 ,
  • Shuang Cheng 2 ,
  • Jin-Yan Sun 2 ,
  • Wei Fang 2 ,
  • Simon Rayner 5 ,
  • Michael A. McVoy 6 ,
  • Xing-Jun Jiang 7 ,
  • Qiyi Tang 8 ,
  • Fang-Cheng Li 1 ,
  • Fei Hu 4 ,
  • Min-Hua Luo 1,2,9
Expand
  • 1. Joint Center of Translational Precision Medicine, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou 510623, China
  • 2. State Key Laboratory of Virology, CAS Center for Excellence in Brain Science and Intelligence Technology, Wuhan Institute of Virology, Wuhan 430071, China
  • 3. Chinese Institute for Brain Research, Beijing 102206, China
  • 4. Wuhan Brain Hospital, Ministry of Transportation, Wuhan 430010, China
  • 5. Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway
  • 6. Department of Pediatrics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA
  • 7. Department of Neurosurgery, Xiangya Hospital, Central South University, Changha 410008, China
  • 8. Department of Microbiology, Howard University College of Medicine, Washington, DC, USA
  • 9. University of Chinese Academy of Sciences, Beijing 100049, China

Published date: 15 Jul 2020

Copyright

2020 The Author(s)
Fold

Cite this article

Le Wen , Fei Zhao , Yong Qiu , Shuang Cheng , Jin-Yan Sun , Wei Fang , Simon Rayner , Michael A. McVoy , Xing-Jun Jiang , Qiyi Tang , Fang-Cheng Li , Fei Hu , Min-Hua Luo . Human cytomegalovirus DNA and immediate early protein 1/2 are highly associated with glioma and prognosis[J]. Protein & Cell, 2020 , 11(7) : 525 -533 . DOI: 10.1007/s13238-020-00696-9

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Cheng S, Jiang X, Yang B, Wen L, Zhao F, Zeng WB, Liu XJ, Dong X, Sun JY, Ming YZ (2017) Infected T98G glioblastoma cells support human cytomegalovirus reactivation from latency. Virology 510:205–215

DOI

2
Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG,Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350

3
Cobbs CS, Soroceanu L, Denham S, Zhang WY, Kraus MH(2008) Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res 68:724–730

DOI

4
Ding DL, Han S, Wang ZX, Guo ZZ, Wu AH (2014) Does the existence of HCMV components predict poor prognosis in glioma? J Neuro-Oncol 116:515–522

DOI

5
Dziurzynski K,Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L,Cobbs CS, HCMV and Gliomas Symposium (2012) Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 14:246–255

DOI

6
Fornara O, Bartek J, Rahbar A, Odeberg J, Khan Z, Peredo I, Hamerlik P, Bartek J, Stragliotto G, Landazuri N (2016) Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact. Cell Death Differ 23:261–269

DOI

7
Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP (2004) Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 96:269–279

DOI

8
Krenzlin H, Behera P, Lorenz V,Passaro C, Zdioruk M, Nowicki MO, Grauwet K,Zhang H, Skubal M, Ito H (2019) Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis. J Clin Invest 129:1671–1683

DOI

9
Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L, Khan KA, Russo L, Algros MP, Valmary-Degano S (2018) The human cytomegalovirus strain db activates oncogenic pathways in mammary epithelial cells. EBioMedicine 30:167–183

DOI

10
Oberstein A, Shenk T (2017) Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype. Proc Natl Acad Sci USA 114: E8244–E8253

DOI

11
Soderberg-Naucler C, Rahbar A, Stragliotto G(2013) Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 369:985–986

DOI

12
Tang KW, Hellstrand K, Larsson E (2015) Absence of cytomegalovirus in high-coverage DNA sequencing of human glioblastoma multiforme. Int J Cancer 136:977–981

DOI

13
Tarrant-Elorza M, Rossetto CC, Pari GS (2014) Maintenance and replication of the human cytomegalovirus genome during latency. Cell Host Microbe 16:43–54

DOI

14
Yamashita Y, Ito Y, Isomura H, Takemura N, Okamoto A, Motomura K, Tsujiuchi T, Natsume A, Wakabayashi T, Toyokuni S (2014) Lack of presence of the human cytomegalovirus in human glioblastoma. Mod Pathol 27:922–929

DOI

15
Young LS, Yap LF, Murray PG (2016) Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer 16:789–802

DOI

Options
Outlines

/

〈 〉